Ocular TherapeutixOCUL

那斯達克 · USD
11.92
+0.34
(+2.94%)
收盤 08/02 03:59 (UTC+8)
盤後 
(0%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.14
  • 0.13
  • 0.15
  • 0.15
  • 0.15
  • 0.15
  • 0.16
  • 0.15
  • 0.17
  • 0.11
icon
  • 17.62
  • -4.98
  • 13.56
  • -0.70
  • -1.86
  • -0.18
  • 11.28
  • -6.17
  • 10.74
  • -37.37
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
10,698
17,082
15,426
16,441
14,774
14,801
15,081
15,187
13,374
14,075
營業成本
1,2621,2301,5611,5091,3261,3861,3781,3031,2141,012
營業毛利
9,436
15,852
13,865
14,932
13,448
13,415
13,703
13,884
12,160
13,063
營業費用
73,35366,42859,86358,52245,06533,46532,91634,45434,70932,424
研發費用
42,85740,98937,05428,85720,73516,19515,01815,09514,74713,543
推銷及管理費用
30,49625,43922,80929,66524,33017,27017,89819,35919,96218,881
非經常性項目費用
----------
其他營業費用
----------
營業利益
-63,917
-50,576
-45,998
-43,590
-31,617
-20,050
-19,213
-20,570
-22,549
-19,361
其他收入及費用
2,8485,29412,7293,009-29,180-5,01922,1241,880-6,0015,666
利息費用
2,9843,1063,2243,1964,0514,1513,4271,9921,7681,847
稅前純益
-64,053
-48,388
-36,493
-43,777
-64,848
-29,220
-516
-20,682
-30,318
-15,542
所得稅
----------
稅後純益
-64,053
-48,388
-36,493
-43,777
-64,848
-29,220
-516
-20,682
-30,318
-15,542
基本每股稅後盈餘(元)
-0.38-0.29-0.22-0.26-0.49--0.01-0.26-0.39-0.20
稀釋每股稅後盈餘(元)
-0.38-0.28-0.21-0.24-0.49-0.25-0.11-0.27-0.39-0.24
基本平均股數(千股)
169396.00168019.00166992.00165824.00132021.00-79373.0078047.0077386.0077010.00
稀釋平均股數(千股)
169396.00168019.00166992.00165824.00132021.00-85142.0078047.0077386.0082779.00
還原基本每股稅後盈餘(元)
-0.38-0.29-0.22-0.26-0.49--0.01-0.26-0.39-0.20
還原稀釋每股稅後盈餘(元)
-0.38-0.28-0.21-0.24-0.49-0.25-0.11-0.27-0.39-0.24
還原基本平均股數(千股)
169,396168,019166,992165,824132,021-79,37378,04777,38677,010
還原稀釋平均股數(千股)
169,396168,019166,992165,824132,021-85,14278,04777,38682,779
EBITDA(千元)
-60,088-44,331-32,310-39,625-59,877-24,1113,801-18,038-28,067-13,204

大家都在看

HOT